Peregrine Capital Management LLC Trims Stake in Avantor, Inc. (NYSE:AVTR)

Peregrine Capital Management LLC cut its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 13.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 686,217 shares of the company's stock after selling 111,038 shares during the period. Peregrine Capital Management LLC owned 0.10% of Avantor worth $15,666,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Park Place Capital Corp raised its position in shares of Avantor by 18.2% in the third quarter. Park Place Capital Corp now owns 3,039 shares of the company's stock valued at $64,000 after buying an additional 467 shares in the last quarter. Cibc World Market Inc. raised its position in shares of Avantor by 1.3% in the first quarter. Cibc World Market Inc. now owns 36,082 shares of the company's stock valued at $1,220,000 after buying an additional 480 shares in the last quarter. Dynamic Advisor Solutions LLC raised its position in shares of Avantor by 3.2% in the third quarter. Dynamic Advisor Solutions LLC now owns 18,598 shares of the company's stock valued at $392,000 after buying an additional 579 shares in the last quarter. Yousif Capital Management LLC raised its position in shares of Avantor by 7.9% in the first quarter. Yousif Capital Management LLC now owns 8,870 shares of the company's stock valued at $300,000 after buying an additional 650 shares in the last quarter. Finally, CIBC Asset Management Inc raised its position in shares of Avantor by 3.1% in the first quarter. CIBC Asset Management Inc now owns 22,009 shares of the company's stock valued at $465,000 after buying an additional 655 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of NYSE AVTR traded up $0.19 during midday trading on Tuesday, reaching $25.86. 3,165,256 shares of the company were exchanged, compared to its average volume of 5,946,069. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. Avantor, Inc. has a one year low of $16.63 and a one year high of $26.16. The stock has a market cap of $17.54 billion, a P/E ratio of 53.48, a PEG ratio of 1.63 and a beta of 1.37. The stock's 50-day moving average price is $24.67 and its 200-day moving average price is $22.23.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The company had revenue of $1.72 billion for the quarter, compared to analysts' expectations of $1.70 billion. During the same quarter in the previous year, the firm posted $0.32 earnings per share. Avantor's revenue for the quarter was down 4.0% on a year-over-year basis. On average, sell-side analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Royal Bank of Canada lifted their price target on shares of Avantor from $28.00 to $29.00 and gave the company an "outperform" rating in a research report on Thursday, February 15th. Citigroup boosted their price objective on shares of Avantor from $24.00 to $30.00 and gave the company a "buy" rating in a research report on Thursday, February 15th. JPMorgan Chase & Co. boosted their price objective on shares of Avantor from $26.00 to $29.00 and gave the company an "overweight" rating in a research report on Thursday, February 15th. Wolfe Research began coverage on shares of Avantor in a research report on Wednesday, December 13th. They set a "peer perform" rating for the company. Finally, Robert W. Baird boosted their price objective on shares of Avantor from $25.00 to $26.00 and gave the company an "outperform" rating in a research report on Thursday, February 15th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $26.29.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the business's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the sale, the executive vice president now owns 101,143 shares of the company's stock, valued at $2,476,992.07. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.30% of the stock is currently owned by insiders.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.